PET/CT

You have access
Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
Stephen A. Graves, Alexandru Bageac, James R. Crowley and Denise A.M. Merlino

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 48S-59S; DOI: https://doi.org/10.2967/jnumed.121.262752
You have access
A Phase II, Open-Label Study to Assess Safety and Management Change Using ⁶⁸Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
Asim Afaq, Heather Payne, Reena Davda, John Hines, Gary J.R. Cook, Marie Meagher, Dimitrios Priftakis, Victoria S. Warbey, Anand Kelkar, Clement Orczyk, Anita Mitra, Sarah Needleman, Michael Ferris, Greg Mullen and Jamshed Bomanji

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1727-1734; DOI: https://doi.org/10.2967/jnumed.120.257527
You have access
Tumor Detection of ¹⁸F-PSMA-1007 in the Prostate Gland in Patients with Prostate Cancer Using Prostatectomy Specimens as Reference Method
Elin Trägårdh, Athanasios Simoulis, Anders Bjartell and Jonas Jögi

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1735-1740; DOI: https://doi.org/10.2967/jnumed.121.261993
You have access
Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in ¹⁸F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis
Can Özütemiz, Yasemin Koksel, Jerry W. Froelich, Nathan Rubin, Maneesh Bhargava, Henri Roukoz, Rebecca Cogswell, Jeremy Markowitz, David M. Perlman and Daniel Steinberger

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1759-1767; DOI: https://doi.org/10.2967/jnumed.121.261981
You have access
GRPr Antagonist ⁶⁸Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients
Ingrid L. Bakker, Alida C. Fröberg, Martijn B. Busstra, J. Fred Verzijlbergen, Mark Konijnenberg, Geert J.L.H. van Leenders, Ivo G. Schoots, Erik de Blois, Wytske M. van Weerden, Simone U. Dalm, Theodosia Maina, Berthold A. Nock and Marion de Jong

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1517-1523; DOI: https://doi.org/10.2967/jnumed.120.258814
You have access
¹⁸F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with ¹⁸F-FDG PET/CT as the Reference Standard
Martijn V. Verhagen, Leon J. Menezes, Deena Neriman, Tom A. Watson, Shonit Punwani, Stuart A. Taylor, Ananth Shankar, Stephen Daw and Paul D. Humphries

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1524-1530; DOI: https://doi.org/10.2967/jnumed.120.260059
You have access
Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for ⁶⁸Ga-PSMA-11 PET/CT
Christian Uprimny, Steffen Bayerschmidt, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica, Hanna Svirydenka, Clemens Decristoforo, Elisabeth von Guggenberg, Wolfgang Horninger and Irene Johanna Virgolini

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1550-1557; DOI: https://doi.org/10.2967/jnumed.120.261866
You have access
Prognostic Value of Bone Marrow Metabolism on Pretreatment ¹⁸F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy
Ryusuke Nakamoto, Lisa C. Zaba, Tie Liang, Sunil Arani Reddy, Guido Davidzon, Carina Mari Aparici, Judy Nguyen, Farshad Moradi, Andrei Iagaru and Benjamin Lewis Franc

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1380-1383; DOI: https://doi.org/10.2967/jnumed.120.254482
You have access
A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of ⁶⁸Ga-NODAGA-LM3 and ⁶⁸Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors
Wenjia Zhu, Yuejuan Cheng, Ru Jia, Hong Zhao, Chunmei Bai, Jianming Xu, Shaobo Yao and Li Huo

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1398-1405; DOI: https://doi.org/10.2967/jnumed.120.253096
You have access
Quantitative ⁶⁸Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE
Claudia Ortega, Rebecca K.S. Wong, Josh Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Amy Liu and Ur Metser

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1406-1414; DOI: https://doi.org/10.2967/jnumed.120.256727

Main menu

User menu

Search

PET/CT

Pages